SCHEMBL30565480

SCHEMBL30565480

Cc1ccc(S(=O)(=O)OC[C@H]2CCC2(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.39
CYP2D6 P10635 4/20 0.39
CYP1A2 P05177 1/20 0.39
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 7/20 0.38
CYP3A4 P08684 4/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
ENPP3 O14638 2/20 0.37
ENPP1 P22413 2/20 0.37
ENPP2 Q13822 2/20 0.37
TSHR P16473 2/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
PKM P14618 1/20 0.35
CRBN Q96SW2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20014121 1.00 STAT3 (0.39) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL20014131 0.92 KMT2A (0.40) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL14972291 0.86 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL17535604 0.86 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL17535652 0.86 ALDH1A1 (0.40) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL23989815 0.85 CTDSP1 (0.37) CYP2D6SMN1; SMN2ALDH1A1CYP3A4CYP2C9
SCHEMBL30030320 0.85 CTDSP1 (0.37) CYP2D6SMN1; SMN2ALDH1A1CYP3A4CYP2C9
SCHEMBL962353 0.79 CYP2D6 (0.39) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL23989830 0.79 ALDH1A1 (0.38) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2
SCHEMBL30030113 0.79 ALDH1A1 (0.38) STAT3CYP2D6CYP1A2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388536-A1 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS HOFFMANN-LA ROCHE INC. (US) 2025-12-25 US disclosed
EP-4486444-A1 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS F. Hoffmann-La Roche AG (CH) 2025-01-08 EP disclosed
WO-2023165943-A1 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2023-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388536-A1 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS CNR2, CNR1, FAAH2 STAT3 4860/4885CYP2D6 973/4885CYP1A2 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.